GPs feel more personalised care for chronically ill patients was useful during coronavirus pandemic During the coronavirus pandemic, GPs had to take over some of the tasks of hospitals and mental healthcare providers.
From 1 October 2023, heel prick test also screens for metabolic disorder ALD From 1 October 2023, the blood of newborn babies will also be tested for the metabolic disorder adrenoleukodystrophy (ALD). This is done with the heel prick screening test.
Post-COVID less common after Omicron infection After a SARS-CoV-2 infection involving Omicron, 1 in 10 people still have symptoms three months later. This is almost 2 times lower than after an infection involving the Delta variant. This is evident from new results of the LongCOVID study at RIVM. There is variation in the frequency of specific post-COVID symptoms after an infection with the Omicron or Delta variant.
Decrease in visits to GP only during first wave of COVID-19 crisis During the first wave of infections in the Netherlands during the COVID-19 crisis (March–June 2020), the total number of visits to the GP was 11% lower than during the same period in 2019.
More than 1 in 5 young people had suicidal thoughts during last lockdown More than 1 in 5 young people (22%) between the ages of 12 and 25 years seriously thought about ending their lives between December 2021 and February 2022. A lockdown was in effect in the Netherlands at that time.
People who work at night are more likely to get infected with coronavirus People who occasionally or regularly work at night are 37% more likely to test positive for coronavirus than people who only work during the daytime. This is one of the conclusions of a study by the RIVM (Netherlands).
First clients and care workers in mental healthcare vaccinated on Monday The first mental health clients in inpatient or residential care in four large institutions in the Netherlands will be vaccinated against COVID-19 this week.
New research in GGD test lanes on spread of coronavirus SARS-CoV-2 RIVM is launching a survey-based study this week on risk factors for the coronavirus SARS-CoV-2. The participants in this study are people who get tested for COVID-19 in a GGD test lane.
New variants disrupt plans In the past week, from 27 January to 2 February, 28,628 people in the Netherlands reportedly tested positive for COVID-19, a 20% decrease compared to the week of 20 to 26 January.
One person died shortly after COVID-19 vaccination The Pharmacovigilance Centre Lareb announced today that the centre had received a report of death shortly after receiving the Pfizer/BioNTech COVID-19 vaccination in the Netherlands.